Clinical Trials Directory

Trials / Unknown

UnknownNCT00599482

Far Infrared Radiation for Sickle Cell Pain Management

Phase 1 Study to Examine the Use of Far Infrared Radiation for Pain Management During Sickle Cell Crisis

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
GAAD Medical Research Institute Inc. · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Most patients with sickle-cell disease have periodic intensely painful episodes. To manage this pain, we are proposing the drinking of at least 500 mL of water followed by far infrared radiation.

Detailed description

Painful sickle cell crises are treated with hydration and analgesics. Ischemia is an absolute or relative shortage of the blood supply to an organ. Relative shortage means the mismatch of blood supply (oxygen delivery) and blood request for adequate oxygenation of tissue. It is hereby postulated that far infrared radiation of the body will promote blood and oxygen supply to the affected tissues. In addition, the analgesic properties of far infrared will alleviate pain due to the crisis.

Conditions

Interventions

TypeNameDescription
RADIATIONFar Infrared Radiation (5μm to 20μm wavelength)Far infrared radiation for 30 to 40 minutes during each session.

Timeline

Start date
2008-01-01
Primary completion
2008-09-01
Completion
2009-01-01
First posted
2008-01-23
Last updated
2009-01-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00599482. Inclusion in this directory is not an endorsement.